MusclePharm Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
8,290.50
1,020.00
7,081.00
4,943.00
6,228.00
Total Accounts Receivable
13,741.20
16,644.00
22,003.00
13,353.00
16,668.00
Inventories
15,772.40
21,069.00
12,549.00
8,568.00
6,484.00
Other Current Assets
6,387.00
7,684.00
5,646.00
1,930.00
1,082.00
Total Current Assets
44,191.00
46,417.00
47,279.00
28,794.00
30,462.00
Net Property, Plant & Equipment
2,613.60
7,805.00
6,693.00
3,243.00
1,822.00
Total Investments and Advances
-
-
977.00
-
-
Intangible Assets
-
7,074.00
8,652.00
1,638.00
1,317.00
Other Assets
5,353.10
5,060.00
180.00
421.00
225.00
Total Assets
52,157.70
66,356.00
63,781.00
34,096.00
33,826.00
ST Debt & Current Portion LT Debt
3,709.80
8,046.00
6,156.00
19,319.00
8,511.00
Accounts Payable
28,393.00
27,761.00
39,652.00
9,625.00
11,742.00
Other Current Liabilities
265.70
7,023.00
21,480.00
9,492.00
8,230.00
Total Current Liabilities
32,368.50
42,830.00
67,288.00
38,436.00
28,483.00
Long-Term Debt
-
146.00
6,282.00
332.00
16,815.00
Provision for Risks & Charges
-
-
279.00
208.00
120.00
Other Liabilities
54.60
-
-
-
942.00
Total Liabilities
32,423.20
42,976.00
73,849.00
38,976.00
46,360.00
Common Equity (Total)
19,734.40
23,380.00
10,068.00
4,880.00
12,534.00
Total Shareholders' Equity
19,734.50
23,380.00
10,068.00
4,880.00
12,534.00
Total Equity
19,734.50
23,380.00
10,068.00
4,880.00
12,534.00
Liabilities & Shareholders' Equity
52,157.70
66,356.00
63,781.00
34,096.00
33,826.00
Preferred Stock (Carrying Value)
0.10
-
-
-
-

About MusclePharm

View Profile
Address
4400 Vanowen Street
Burbank California 91505
United States
Employees -
Website http://www.musclepharm.com
Updated 07/08/2019
MusclePharm Corp. develops, manufactures, markets, and distributes branded nutritional supplements. Its portfolio of recognized brands include MusclePharm Sport Series, Essential Series and FitMiss, as well as Natural Series. Its products include performance powders, capsules, tablets, and gels.